150 related articles for article (PubMed ID: 7306963)
1. Reduction of tumorigenicity and of dihydrodiol formation by fluorine substitution in the angular rings of dibenzo(a,i)pyrene.
Hecht SS; LaVoie EJ; Bedenko V; Pingaro L; Katayama S; Hoffmann D; Sardella DJ; Boger E; Lehr RE
Cancer Res; 1981 Nov; 41(11 Pt 1):4341-5. PubMed ID: 7306963
[TBL] [Abstract][Full Text] [Related]
2. Metabolism and tumorigenicity of 7-, 8-, 9-, and 10-fluorobenzo(a)pyrenes.
Buhler DR; Unlu F; Thakker DR; Slaga TJ; Newman MS; Levin W; Conney AH; Jerina DM
Cancer Res; 1982 Nov; 42(11):4779-83. PubMed ID: 6290047
[TBL] [Abstract][Full Text] [Related]
3. Tumor-initiating activity of dihydrodiols formed metabolically from 5-methylchrysene.
Hecht SS; Rivenson A; Hoffmann D
Cancer Res; 1980 May; 40(5):1396-9. PubMed ID: 7370979
[TBL] [Abstract][Full Text] [Related]
4. Comparative dose-response tumorigenicity studies of dibenzo[alpha,l]pyrene versus 7,12-dimethylbenz[alpha]anthracene, benzo[alpha]pyrene and two dibenzo[alpha,l]pyrene dihydrodiols in mouse skin and rat mammary gland.
Cavalieri EL; Higginbotham S; RamaKrishna NV; Devanesan PD; Todorovic R; Rogan EG; Salmasi S
Carcinogenesis; 1991 Oct; 12(10):1939-44. PubMed ID: 1934274
[TBL] [Abstract][Full Text] [Related]
5. Tumor-initiating activity and metabolism of polymethylated phenanthrenes.
LaVoie EJ; Bedenko V; Tulley-Freiler L; Hoffmann D
Cancer Res; 1982 Oct; 42(10):4045-9. PubMed ID: 7105001
[TBL] [Abstract][Full Text] [Related]
6. Metabolic activation of the (+)-S,S- and (-)-R,R-enantiomers of trans-11,12-dihydroxy-11,12-dihydrodibenzo[a,l]pyrene: stereoselectivity, DNA adduct formation, and mutagenicity in Chinese hamster V79 cells.
Luch A; Seidel A; Glatt H; Platt KL
Chem Res Toxicol; 1997 Oct; 10(10):1161-70. PubMed ID: 9348439
[TBL] [Abstract][Full Text] [Related]
7. Tumor formation in the neonatal mouse bioassay indicates that the potent carcinogen dibenzo[def,p]chrysene (dibenzo[a,l]pyrene) is activated in vivo via its trans-11,12-dihydrodiol.
Platt KL; Dienes HP; Tommasone M; Luch A
Chem Biol Interact; 2004 Jun; 148(1-2):27-36. PubMed ID: 15223354
[TBL] [Abstract][Full Text] [Related]
8. High tumorigenicity of the 3,4-dihydrodiol of 7-methylbenz[c]acridine on mouse skin and in newborn mice.
Chang RL; Levin W; Wood AW; Shirai N; Ryan AJ; Duke CC; Jerina DM; Holder GM; Conney AH
Cancer Res; 1986 Sep; 46(9):4552-5. PubMed ID: 3731110
[TBL] [Abstract][Full Text] [Related]
9. Tumorigenic activity of benzo(e)pyrene derivatives on mouse skin and in newborn mice.
Buening MK; Levin W; Wood AW; Chang RL; Lehr RE; Taylor CW; Yagi H; Jerina DM; Conney AH
Cancer Res; 1980 Feb; 40(2):203-6. PubMed ID: 7356502
[TBL] [Abstract][Full Text] [Related]
10. Mutagenicity, tumor-initiating activity, and metabolism of methylphenanthrenes.
LaVoie EJ; Tulley-Freiler L; Bedenko V; Hoffman D
Cancer Res; 1981 Sep; 41(9 Pt 1):3441-7. PubMed ID: 7020927
[TBL] [Abstract][Full Text] [Related]
11. Evidence for bay region activation of chrysene 1,2-dihydrodiol to an ultimate carcinogen.
Levin W; Wood AW; Chang RL; Yagi H; Mah HD; Jerina DM; Conney AH
Cancer Res; 1978 Jun; 38(6):1831-4. PubMed ID: 647691
[TBL] [Abstract][Full Text] [Related]
12. Marked differences in the tumor-initiating activity of optically pure (+)- and (-)-trans-7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene on mouse skin.
Levin W; Wood AW; Chang RL; Slaga TJ; Yagi H; Jerina DM; Conney AH
Cancer Res; 1977 Aug; 37(8 Pt 1):2721-5. PubMed ID: 872099
[TBL] [Abstract][Full Text] [Related]
13. High stereoselectivity among the optical isomers of the diastereomeric bay-region diol-epoxides of benz(a)anthracene in the expression of tumorigenic activity in murine tumor models.
Levin W; Chang RL; Wood AW; Yagi H; Thakker DR; Jerina DM; Conney AH
Cancer Res; 1984 Mar; 44(3):929-33. PubMed ID: 6692415
[TBL] [Abstract][Full Text] [Related]
14. Tumor-initiating activity and carcinogenicity of dibenzo[a,l]pyrene versus 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene at low doses in mouse skin.
Higginbotham S; RamaKrishna NV; Johansson SL; Rogan EG; Cavalieri EL
Carcinogenesis; 1993 May; 14(5):875-8. PubMed ID: 8504480
[TBL] [Abstract][Full Text] [Related]
15. Comparative tumor-initiating activity of methylated benzo(a)pyrene derivatives in mouse skin.
Iyer RP; Lyga JW; Secrist JA; Daub GH; Slaga TJ
Cancer Res; 1980 Apr; 40(4):1073-6. PubMed ID: 7357537
[TBL] [Abstract][Full Text] [Related]
16. Skin tumor-initiating activities of the twelve isomeric phenols of benzo(a)pyrene.
Slaga TJ; Bracken WM; Dresner S; Levin W; Yagi H; Jerina DM; Conney AH
Cancer Res; 1978 Mar; 38(3):678-81. PubMed ID: 626971
[TBL] [Abstract][Full Text] [Related]
17. Effects of fluorine substitution on the tumor initiating activity and metabolism of 5-hydroxymethylchrysene, a tumorigenic metabolite of 5-methylchrysene.
Amin S; Juchatz A; Furuya K; Hecht SS
Carcinogenesis; 1981; 2(10):1027-32. PubMed ID: 7296756
[TBL] [Abstract][Full Text] [Related]
18. Carcinogenicity of benzo-ring derivatives of benzo(a)pyrene on mouse skin.
Levin W; Wood AW; Wislocki PG; Kapitulnik J; Yagi H; Jerina DM; Conney AH
Cancer Res; 1977 Sep; 37(9):3356-61. PubMed ID: 884679
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory response of mouse skin exposed to the very potent carcinogen dibenzo[a,l]pyrene: a model for tumor promotion.
Casale GP; Higginbotham S; Johansson SL; Rogan EG; Cavalieri EL
Fundam Appl Toxicol; 1997 Mar; 36(1):71-8. PubMed ID: 9073469
[TBL] [Abstract][Full Text] [Related]
20. Tumor-initiating activity of benz[c]acridine and twelve of its derivatives on mouse skin.
Levin W; Wood AW; Chang RL; Kumar S; Yagi H; Jerina DM; Lehr RE; Conney AH
Cancer Res; 1983 Oct; 43(10):4625-8. PubMed ID: 6883319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
